Skip to content

Effect of a Laxative on progression of CKD

Effect of a Laxative on progression of CKD - J-LUBIC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017430
Enrollment
50
Registered
2015-05-06
Start date
2014-02-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease (CKD)

Interventions

Administration of lubiprostone to CKD patients

Sponsors

Tohoku University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: CKD patients with constipation

Exclusion criteria

Exclusion criteria: ileus

Design outcomes

Primary

MeasureTime frame
constipation Concentration of uremic toxins Renal funcitons

Secondary

MeasureTime frame
gutmicrobiota

Countries

Japan

Contacts

Public ContactTakaaki ABE

Tohoku University Graduate School of Biomedical Engineering Division of Medical Science

takaabe@med.tohoku.ac.jp022-717-7163

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026